| 1 | Q9Y3Q4 | HCN4 | T30286 | Literature-reported Target |
| 2 | Q96RI0 | F2RL3 | T30414 | Literature-reported Target |
| 3 | Q9NQR1 | KMT5A | T30420 | Preclinical target | - Liver cancer
- Solid tumour/cancer
|
| 4 | Q9H0K1 | SIK2 | T30495 | Clinical trial target |
| 5 | Q9NPC1 | LTB4R2 | T30563 | Clinical trial target | - Human immunodeficiency virus disease
- Renal cell carcinoma
| - [ICD-11: 1C60-1C62]
- [ICD-11: 2C90]
|
| 6 | P02778 | CXCL10 | T30635 | Clinical trial target | - Crohn disease
- Diabetes mellitus
- Immune system disease
- Indeterminate colitis
- Solid tumour/cancer
- Ulcerative colitis
| - [ICD-11: DD70]
- [ICD-11: 5A10]
- [ICD-11: 4A01-4B41]
- [ICD-11: DD72]
- [ICD-11: 2A00-2F9Z]
- [ICD-11: DD71]
| - Diseases of the digestive system
- Endocrine, nutritional or metabolic diseases
- Diseases of the immune system
- Diseases of the digestive system
- Neoplasms
- Diseases of the digestive system
|
| 7 | P01042 | KNG1 | T30731 | Clinical trial target |
| 8 | P00390 | GSR | T30803 | Patented-recorded Target |
| 9 | O15269 | SPTLC1 | T30817 | Literature-reported Target |
| 10 | P21673 | SAT1 | T30844 | Literature-reported Target |
| 11 | P62993 | GRB2 | T30926 | Clinical trial target | - Acute myeloid leukaemia
- Malignant haematopoietic neoplasm
- Mature B-cell lymphoma
- Myelodysplastic syndrome
- Myeloproliferative neoplasm
| - [ICD-11: 2A60]
- [ICD-11: 2B33]
- [ICD-11: 2A85]
- [ICD-11: 2A37]
- [ICD-11: 2A20]
|
| 12 | P25021 | HRH2 | T30985 | Successful Target | - Gastro-oesophageal reflux disease
- Oesophageal/gastroduodenal disorder
- Peptic ulcer
| - [ICD-11: DA22]
- [ICD-11: DD90]
- [ICD-11: DA61]
|
| 13 | P06730 | EIF4E | T31186 | Literature-reported Target |
| 14 | P41595 | HTR2B | T31204 | Successful Target | - Attention deficit hyperactivity disorder
- Depression
- Pituitary gland disorder
- Psychotic disorder
| - [ICD-11: 6A05]
- [ICD-11: 6A70-6A7Z]
- [ICD-11: 5A60-5A61]
- [ICD-11: 6A20-6A25]
| - Mental, behavioural or neurodevelopmental disorders
- Mental, behavioural or neurodevelopmental disorders
- Endocrine, nutritional or metabolic diseases
- Mental, behavioural or neurodevelopmental disorders
|
| 15 | P10415 | BCL2 | T31309 | Successful Target | - Breast cancer
- Mature B-cell leukaemia
- Motor neuron disease
- Solid tumour/cancer
| - [ICD-11: 2C60-2C6Y]
- [ICD-11: 2A82]
- [ICD-11: 8B60]
- [ICD-11: 2A00-2F9Z]
|
| 16 | P27487 | DPP4 | T31391 | Successful Target | - Acute diabete complication
- Type 2 diabetes mellitus
| - [ICD-11: 5A2Y]
- [ICD-11: 5A11]
| - Endocrine, nutritional or metabolic diseases
- Endocrine, nutritional or metabolic diseases
|
| 17 | P08631 | HCK | T31406 | Patented-recorded Target |
| 18 | P04054 | PLA2G1B | T31479 | Successful Target | - Leishmaniasis
- Peroxisomal disease
- Rosacea
- Synthesis disorder
| - [ICD-11: 1F54]
- [ICD-11: 5C57]
- [ICD-11: ED90]
- [ICD-11: 5C52-5C59]
| - Certain infectious or parasitic diseases
- Endocrine, nutritional or metabolic diseases
- Diseases of the skin
- Endocrine, nutritional or metabolic diseases
|
| 19 | P10253 | GAA | T31514 | Successful Target |
| 20 | Q9Y5Y6 | ST14 | T31543 | Patented-recorded Target |
| 21 | Q99519 | NEU1 | T31595 | Successful Target |
| 22 | P09038 | FGF2 | T31621 | Successful Target |
| 23 | P43005 | SLC1A1 | T31721 | Literature-reported Target |
| 24 | O15427 | SLC16A3 | T31788 | Literature-reported Target |
| 25 | O14672 | ADAM10 | T31902 | Clinical trial target |